Table 3.
Comparison of clinical parameters between the two groups determined by the hepatic steatosis criterion (c; CTL-S < −10).
| Patients with Hepatic Steatosis (n = 34) | Patients without Hepatic Steatosis (n = 305) | p-Value | ||
|---|---|---|---|---|
| Univariate Analysis | Multivariate Analysis | |||
| AST (IU/L) | 32 ± 16.5 | 25 ± 12 | 0.151 | |
| ALT (IU/L) | 38.5 ± 35.5 | 25 ± 14 | 0.053 | |
| Fasting glucose (mg/dL) | 110.5 ± 29.25 | 98 ± 18 | 0.004 | 0.292 |
| HbA1c (%) | 6.25 ± 1.25 | 5.6 ± 0.5 | 0.002 | 0.891 |
| Triglyceride (mg/dL) | 160 ± 148.25 | 94 ± 83 | <0.001 | 0.11 |
| Total cholesterol (mg/dL) | 207.5 ± 78 | 203 ± 55 | 0.006 | 0.391 |
| HDL (mg/dL) | 46 ± 19 | 57 ± 20 | 0.052 | |
| LDL (mg/dL) | 120.5 ± 65.25 | 123 ± 50 | 0.957 | |
| Uric acid (mg/dL) | 5.4 ± 2 | 4.8 ± 1.9 | 0.005 | 0.111 |
| ALT/AST ratio | 1.3 ± 0.53 | 0.94 ± 0.37 | 0.006 | 0.028 |
| HSI | 37.68 ± 6.26 | 32.54 ± 6.78 | <0.001 | 0.028 |
| BMI (kg/m2) | 26 ± 4.18 | 23.6 ± 4.3 | 0.001 | 0.081 |
Data are median ± IQR values. AST: aspartate aminotransferase, ALT: alanine aminotransferase, HbA1c: hemoglobin A1c, HDL: high-density lipoprotein, LDL: low-density lipoprotein, HSI: hepatic steatosis index, BMI: body mass index, IQR: interquartile range.